biologicals < biologics < biology

Facettes : Author.f AffPays.f AffRegion.f AffVille.f AffOrg.f Mesh.f MeshFr.f Teeft.f

List of bibliographic references

Number of relevant bibliographic references: 21.
[0-20] [0 - 20][0 - 21][20-20][20-40]

Ident.	Authors (with country if any)	Title
000014 (2020)	Puja Mehta ; Jessica J. Manson	What Is the Clinical Relevance of TNF Inhibitor Immunogenicity in the Management of Patients With Rheumatoid Arthritis?
000023 (2020)	Yehyun Park [Corée du Sud] ; Jae Hee Cheon [Corée du Sud]	Update on the Treatment of Behcet's Disease of the Small Bowel with Biologic Agents.
000088 (2020)	N. Ghalandari ; R. J. E. M. Dolhain ; J. M. W. Hazes ; C. L. E. Siezen ; J. W. Van Der Laan ; H. J. M. J. Crijns ; E. P. Van Puijenbroek ; C. J. Van Der Woude	The pre‐ and post‐authorisation data published by the European medicines agency on the use of biologics during pregnancy and lactation
000091 (2020)	Guillaume Decarriere [France] ; Thomas Barnetche [France] ; Bernard Combe [France] ; Cécile Gaujoux-Viala [France] ; Cédric Lukas [France] ; Jacques Morel [France] ; Claire Daien [France]	The most appropriate conventional DMARD to combine with different advanced therapies in rheumatoid arthritis: a systematic literature review with meta-analysis.
000169 (2020)	Maria Antonietta Barbieri [Italie] ; Giuseppe Cicala [Italie] ; Paola Maria Cutroneo [Italie] ; Elisabetta Gerratana [Italie] ; Caterina Palleria [Italie] ; Caterina De Sarro [Italie] ; Ada Vero [Italie] ; Luigi Iannone [Italie] ; Antonia Manti [Italie] ; Emilio Russo [Italie] ; Giovambattista De Sarro [Italie] ; Fabiola Atzeni [Italie] ; Edoardo Spina [Italie]	Safety Profile of Biologics Used in Rheumatology: An Italian Prospective Pharmacovigilance Study.
000235 (2020)	Nikita Mehta [États-Unis] ; Maryann Mazer-Amirshahi [États-Unis] ; Nour Alkindi [États-Unis]	Pharmacotherapy in COVID-19; A narrative review for emergency providers
000237 (2020)	Zaid H. Temrikar [États-Unis] ; Satyendra Suryawanshi [États-Unis] ; Bernd Meibohm [États-Unis]	Pharmacokinetics and Clinical Pharmacology of Monoclonal Antibodies in Pediatric Patients
000241 (2020)	Nick Bansback ; Jeffrey R. Curtis ; Jie Huang ; Zeling He ; Michael Evans ; Tracy Johansson ; Kaleb Michaud ; Gabriela Schmajuk ; Katherine P. Liao	Patterns of Tumor Necrosis Factor Inhibitor (TNFi) Biosimilar Use Across United States Rheumatology Practices
000260 (2020)	Ruksana Huda	New Approaches to Targeting B Cells for Myasthenia Gravis Therapy
000331 (2020)	Anne Y. Liu [États-Unis]	Infectious Implications of Interleukin-1, Interleukin-6, and T Helper Type 2 Inhibition.
000332 (2020)	Ying-Ming Chiu [Taïwan] ; Der-Yuan Chen [Taïwan]	Infection risk in patients undergoing treatment for inflammatory arthritis: non-biologics versus biologics.
000361 (2020)	Kunihiko Umekita ; Akihiko Okayama	HTLV-1 Infection and Rheumatic Diseases
000390 (2020)	Patricia Richi [Espagne] ; Oriol Alonso [Espagne] ; María Dolores Martín [Espagne] ; Laura González-Hombrado [Espagne] ; Teresa Navío [Espagne] ; Marina Salido [Espagne] ; Jesús Llorente [Espagne] ; Cristina Andreu-Vázquez [Espagne] ; Cristina García-Fernández [Espagne] ; Ana Jiménez-Diaz [Espagne] ; Leticia Lojo [Espagne] ; Laura Cebrián [Espagne] ; Israel Thuissard-Vasallo [Espagne] ; María José Martínez De Aramayona [Espagne] ; Tatiana Cobo [Espagne] ; Marta García-Castro [Espagne] ; Patricia Castro [Espagne] ; M Nica Fernández-Castro [Espagne] ; Scar Illera [Espagne] ; Martina Steiner [Espagne] ; Santiago Mu Oz-Fernández [Espagne]	Evaluation of the immune response to hepatitis B vaccine in patients on biological therapy: results of the RIER cohort study.
000394 (2020)	Alberto Meneguzzo ; Annalisa Lazzarotto ; Mauro Alaibac	Eruptive Melanocytic Nevi Secondary to Encorafenib for BRAF Mutant Metastatic Colorectal Cancer
000432 (2020)	Kosuke Ebina [Japon] ; Toru Hirano [Japon] ; Yuichi Maeda [Japon] ; Wataru Yamamoto [Japon] ; Motomu Hashimoto [Japon] ; Koichi Murata [Japon] ; Tohru Takeuchi [Japon] ; Koji Nagai [Japon] ; Yonsu Son [Japon] ; Hideki Amuro [Japon] ; Akira Onishi [Japon] ; Sadao Jinno [Japon] ; Ryota Hara [Japon] ; Masaki Katayama [Japon] ; Keiichi Yamamoto [Japon] ; Atsushi Kumanogoh [Japon] ; Makoto Hirao [Japon]	Drug retention of secondary biologics or JAK inhibitors after tocilizumab or abatacept failure as first biologics in patients with rheumatoid arthritis -the ANSWER cohort study.
000433 (2020)	Corrado Campochiaro [Italie] ; Alessandro Tomelleri [Italie] ; Silvia Sartorelli [Italie] ; Giulio Cavalli [Italie] ; Giacomo De Luca [Italie] ; Elena Baldissera [Italie] ; Lorenzo Dagna [Italie]	Drug retention and discontinuation reasons between seven biologics in patients with Takayasu arteritis.
000441 (2020)	Ruei-Min Lu [Taïwan] ; Yu-Chyi Hwang [Taïwan] ; I-Ju Liu [Taïwan] ; Chi-Chiu Lee [Taïwan] ; Han-Zen Tsai [Taïwan] ; Hsin-Jung Li [Taïwan] ; Han-Chung Wu [Taïwan]	Development of therapeutic antibodies for the treatment of diseases
000487 (2020)	Siddharth Singh ; Mathurin Fumery [France] ; Abha G. Singh ; Namrata Singh [États-Unis] ; Larry J. Prokop [États-Unis] ; Parambir S. Dulai ; William J. Sandborn ; Jeffrey R. Curtis	Comparative Risk of Cardiovascular Events With Biologic and Synthetic Disease-Modifying Antirheumatic Drugs in Patients With Rheumatoid Arthritis: A Systematic Review and Meta-Analysis.
000563 (2020)	Parth Shah ; Vinay Sundaram ; Einar Björnsson	Biologic and Checkpoint Inhibitor‐Induced Liver Injury: A Systematic Literature Review
000571 (2020)	Seong-Kyu Kim ; Sang Gyu Kwak [Corée du Sud] ; Jung-Yoon Choe	Association between biologic disease modifying anti-rheumatic drugs and incident hypertension in patients with rheumatoid arthritis: Results from prospective nationwide KOBIO Registry.
000574 (2020)	Alexandra Erath [États-Unis] ; Stacie B. Dusetzina [États-Unis]	Assessment of Expected Out-of-Pocket Spending for Rheumatoid Arthritis Biologics Among Patients Enrolled in Medicare Part D, 2010-2019

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/2020/Analysis

HfdIndexSelect -h $EXPLOR_AREA/Data/2020/Analysis/AbsEn.i -k "biologics" 

HfdIndexSelect -h $EXPLOR_AREA/Data/2020/Analysis/AbsEn.i  \
                -Sk "biologics" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/2020/Analysis/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    2020
   |étape=   Analysis
   |type=    indexItem
   |index=    AbsEn.i
   |clé=    biologics
}}

---

This area was generated with Dilib version V0.6.34. Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021